Aytu Biopharma (AYTU) Non Operating Income (2010 - 2023)
Aytu Biopharma (AYTU) posted quarterly Non Operating Income of -$6.6 million for Q3 2023, down 697.65% year-over-year from $1.1 million in Q3 2022, and down 151.94% quarter-over-quarter from -$2.6 million in Q2 2023.
Aytu Biopharma (AYTU) Non Operating Income (2010 - 2023) Analysis & Trends
Aytu Biopharma (AYTU) has reported Non Operating Income for 14 consecutive years, with -$6.6 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Non Operating Income fell 697.65% year-over-year to -$6.6 million; the TTM figure through Sep 2023 stood at -$7.8 million (down 525.12% YoY), while the FY2023 annual figure was $14000.0, down 98.62% from the prior year.
- Non Operating Income slipped to -$6.6 million in Q3 2023 per AYTU's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $8.7 million in Q2 2020 and bottomed at -$10.0 million in Q2 2019.
- Historically, Non Operating Income has averaged -$167527.4 across 5 years, with a median of -$195390.0 in 2019.
- Annual changes were most pronounced in 2019 — Non Operating Income jumped 4544.74% — and 2023, when it plunged 697.65%.
- Aytu Biopharma's Non Operating Income stood at $4.8 million in 2019, then slumped by 183.11% to -$4.0 million in 2020, then surged by 93.49% to -$257000.0 in 2021, then jumped by 138.91% to $100000.0 in 2022, then sank by 6716.0% to -$6.6 million in 2023.
- Business Quant data shows AYTU's Non Operating Income at -$6.6 million in Q3 2023, -$2.6 million in Q2 2023, and $1.4 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -6.62 Mn |
| Jun 30, 2023 | -2.63 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 851,000.00 |
| Mar 31, 2022 | 130,000.00 |
| Dec 31, 2021 | -257,000.00 |
| Sep 30, 2021 | -259,000.00 |
| Jun 30, 2021 | 5.33 Mn |
| Dec 31, 2020 | -3.95 Mn |
| Sep 30, 2020 | -749,000.00 |
| Jun 30, 2020 | 8.69 Mn |
| Mar 31, 2020 | -538,862.00 |
| Dec 31, 2019 | 4.75 Mn |
| Sep 30, 2019 | -193,556.00 |
| Jun 30, 2019 | -9.95 Mn |
| Mar 31, 2019 | -197,224.00 |
| Dec 31, 2018 | -106,932.00 |
| Sep 30, 2018 | -29,209.00 |